| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.062 | 0.2 |